Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06069479

Comparing Conservative to Surgical Treatment of Trigonocephaly Craniofacial Surgery in Children With Trigonocephaly: an Observational Cohort Study on Clinical Outcomes, Psychosocial Wellbeing, and Costs

RESEARCH QUESTION Is the effectiveness of conservative policy comparable to that of surgery in children with trigonocephaly, with regard to clinical outcomes and psychosocial functioning, stress for parents, and costs? DESIGN Observational cohort study in children, aged 0 to 8 years old, with trigonocephaly, excluding metopic ridging (physiologic early closure of metopic suture), treated conservatively or surgically.

OUTCOME MEASURES Primary: Head growth decline, indicating raised intracranial pressure Secondary: fundoscopy, cognition, behavior, refraction and vision, forehead shape, quality of life, posttraumatic stress, decisional conflict, costs.

Recruiting

Interested in participating?

Request Info

Key information

Age range

Up to 8 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Erasmus MC

Rotterdam, ROTTERDAM, 3012LE, Netherlands

Location status: Recruiting

Location contact

Irene MJ Mathijssen, MD, PhD, MBA-H

CONTACT

[email protected]

+31655758441

About this study

HYPOTHESIS Conservative treatment is non-inferior to surgery with regard to clinical outcomes, causes less burden of disease, and is cost-effective.

STUDY DESIGN Observational cohort study STUDY POPULATION Children, aged 0 to 8 years old, with trigonocephaly, excluding metopic ridging (physiologic early closure of metopic suture) INTERVENTION Conservative policy USUAL CARE/COMPARISON Craniofacial surgery OUTCOME MEASURES Primary: Head growth decline (head circumference in SD), indicating raised intracranial pressure Secondary: fundoscopy, cognition, behavior, refraction and vision, forehead shape, quality of life, posttraumatic stress, decisional conflict, costs. Repeated measures at 0, 2, 4, 6, 8 years of age SAMPLE SIZE/DATA ANALYSIS Eligible patients <= 3 years of age are included since Sept 2022 Sample size 440 patients <1 year of age: 195 surgery and 245 conservative

Non-inferiority with regard to head growth from 0-4 years (annual measurement) is determined using a linear mixed model adjusted for confounders:

severity of phenotype, sex, syndrome and parental factors (e.g., education). COST-EFFECTIVINESS ANALYSIS/BIA An economic evaluation is performed with the incorporation of medical costs and costs due to loss of productivity for the parents. A detailed costs-study is done for medical specialist care, surgical costs, hospitalization and other costs directly associated with the interventions. Cost prizes of surgery will be determined by the bottom-up micro-costing method. Cost-utility will be measured with QALY (based on EQ-5D utility score) gained, with confidence ellipses and acceptability curves. The impact of conservative policy versus surgery will be investigated on assurance perspective and central level. From the viewpoint of the (health care) government, a societal perspective and perspective of the "budgettair kader zorg" will be highlighted. We will provide a valid framework with budget consequences by a range of predictions. Sensitivity analysis is done.

TIME SCHEDULE Inclusion between Sept 2022 and Sept 2030. Analysis and reporting for each outcome parameter related to age is distributed from January 2025 to September 2031. New recommendation for treatment of trigonocephaly in guideline ready in 2031.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of trigonocephaly

Exclusion criteria

  • metopic ridge (physiologic early closure of metopic suture)

Treatment and study plan

craniofacial surgery

Procedure

Surgical treatment, either stripcraniectomy or fronto-orbital advancement

Primary outcomes

  1. Head growth

    Time frame: from 0 to 8 years old

    Annual measurement of head circumference in SD for gender and age. Decline in head growth may indicate raised intracranial pressure

Secondary outcomes

  1. fundoscopy

    Time frame: from 1 to 4 years old

    Annual screening for presence of papilledema as sign of raised intracranial pressure

  2. Cognition and behavior

    Time frame: at 0, 2, 4 and 8 years old

    Validated tests for cognition and behavior of the child

  3. refraction and vision

    Time frame: at 1, 4 and 8 years old

    tests taken by orthoptist

  4. forehead shape

    Time frame: at 0, 2, 4, 6 and 8 years old

    3D photos (objective) and VAS score by parents (subjective) to grade the forehead shape

  5. Quality of life and post-traumatic stress

    Time frame: at 0, 2, 4, 6 and 8 years old

    Validated tests to measure quality of life of the child and parents and presence of PTS in parents

  6. Decisional conflict

    Time frame: at 8 years old

    questionnaire to determine whether or not parents are still content with their decision on type of treatment

Study contacts

Contact information is provided by the study sponsor or research team.

Irene MJ Mathijssen, MD, PhD, MBA-H

CONTACT

[email protected]

+31655758441

Sponsors and collaborators

Lead sponsor

Erasmus Medical Center

Other

Collaborators

  • IJsselland Hospital
  • LAPOSA
  • Sint Franciscus Gasthuis

Registry information

Official study title

Comparing Effectiveness of a Conservative Policy to Craniofacial Surgery in Children With Trigonocephaly: an Observational Cohort Study on Clinical Outcomes, Psychosocial Wellbeing, and Costs

Acronym: Treat Trigono

Important dates

Study start
2022
Primary completion
2031
Study completion
2031
First posted
Oct 5, 2023
Registry last updated
Aug 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.